Mark Avagliano

Insider Reports History

Location
Research Triangle Park, NC
Signature
/S/ Monica Roberts Thomas, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Avagliano:

Company Role Class Num Shares Value Price $ Report Date Ownership
G1 Therapeutics, Inc. Chief Business Officer Common Stock 0 $0 $2.51 18 Sep 2024 Direct
G1 Therapeutics, Inc. Chief Business Officer Stock Option (right to buy) 0 18 Sep 2024 Direct

Insider Reports Filed by Mark Avagliano

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024107795-avagliano-mark-2024-09-18 G1 Therapeutics, Inc. 18 Sep 2024 5 $0 4 Chief Business Officer 18 Sep 2024, 16:15
/report/000156218024005657-avagliano-mark-2024-07-05 G1 Therapeutics, Inc. 05 Jul 2024 1 -$6,615 4 Chief Business Officer 08 Jul 2024, 17:55
/report/000156218024005605-avagliano-mark-2024-07-01 G1 Therapeutics, Inc. 01 Jul 2024 1 $0 4 Chief Business Officer 03 Jul 2024, 17:26
/report/000156218024004057-avagliano-mark-2024-05-13 G1 Therapeutics, Inc. 13 May 2024 1 -$39,034 4 Chief Business Officer 15 May 2024, 16:07
/report/000156218024002949-avagliano-mark-2024-03-20 G1 Therapeutics, Inc. 20 Mar 2024 1 $0 4 Chief Business Officer 22 Mar 2024, 16:09
/report/000156218024000323-avagliano-mark-2024-01-03 G1 Therapeutics, Inc. 03 Jan 2024 5 -$12,601 4 Chief Business Officer 08 Jan 2024, 06:02
/report/000156218023004098-avagliano-mark-2023-05-10 G1 Therapeutics, Inc. 10 May 2023 1 $0 4 Chief Business Officer 12 May 2023, 16:20
/report/000156218023000251-avagliano-mark-2023-01-03 G1 Therapeutics, Inc. 03 Jan 2023 2 $0 4 Chief Business Officer 05 Jan 2023, 19:25
/report/000156218022000303-avagliano-mark-2022-01-03 G1 Therapeutics, Inc. 03 Jan 2022 3 -$15,334 4 Chief Business Officer 05 Jan 2022, 19:24